US FDA to Approve Leucovorin for Cerebral Folate Deficiency
The U.S. Food and Drug Administration (FDA) has started the process to approve leucovorin calcium tablets as a treatment for patients with cerebral folate...
Merck and Siemens to Accelerate AI Driven Drug Development
Merck and Siemens have expanded their collaboration by signing a new Memorandum of Understanding (MoU) aimed at advancing digital transformation in the life science...
ABPI Launches Manifesto to Advance Scottish Pharma Sector
The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...
FDA Grant Approval for Opzelura Cream for Pediatric Eczema
The U.S. Food and Drug Administration has granted approval to Incyte’s eczema cream, Opzelura, for use in children aged 2 to 11 years, the...
GSK to Invest $30B in Drug Manufacturing and R&D in the US
GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United States. The announcement includes...
Amneal Secures FDA Approval for Sodium Oxybate Oral Solution
Amneal Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company’s sodium oxybate oral solution 500...
US FDA Tightens Oversight on Misleading Drug Advertising
The U.S. Food and Drug Administration (FDA) announced that it will issue approximately 100 cease-and-desist enforcement notices alongside thousands of warning letters directed at...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...